Cancer Harboring BRAF Alterations research hub

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

This study is looking into a new medication called plixorafenib for people with certain types of cancer, including brain tumours, that have a specific change in their BRAF gene. It aims to see how well it works and if it's safe.